Published in Adv Surg on January 01, 1966
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J (1968) 4.38
Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78
Homotransplantation of the liver. Transplantation (1967) 1.71
Immunopathological studies of orthotopic human liver allografts. Lancet (1972) 1.07
A modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker~Debakey Clinical Medical Research Award. J Clin Invest (2012) 0.76
Hepatic Disorders in Renal Homograft Recipients. Curr Top Surg Res (1969) 0.75
The control of circulation through the liver. J Physiol (1932) 22.89
Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow. Surg Gynecol Obstet (1960) 11.73
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. Surg Gynecol Obstet (1963) 10.22
Experimental whole-organ transplantation of the liver and of the spleen. Ann Surg (1960) 9.58
THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE. Surg Gynecol Obstet (1963) 8.04
FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG. Surgery (1965) 6.71
Homotransplantation of the canine liver. Surgery (1956) 6.45
Cellular changes in lymph nodes and spleen following skin homografting in the rabbit. J Anat (1955) 5.16
IMMUNOSUPPRESSION AFTER EXPERIMENTAL AND CLINICAL HOMOTRANSPLANTATION OF THE LIVER. Ann Surg (1964) 4.14
Studies on the rejection of the transplanted homologous dog liver. Surg Gynecol Obstet (1961) 3.81
EXTRACORPOREAL PERFUSION FOR OBTAINING POSTMORTEM HOMOGRAFTS. Surgery (1963) 3.72
One-stage homotransplantation of the liver following total hepatectomy in dogs. Transplant Bull (1959) 3.62
Zone electrophoresis in starch gels and its application to studies of serum proteins. Adv Protein Chem (1959) 3.47
Human renal transplantation. I. Clinical experiences with six cases of renal homotransplantation. J Urol (1963) 3.35
Liver regeneration following portacaval transposition in dogs. Ann Surg (1953) 3.23
PHYSIOLOGIC REQUIREMENTS FOR AUXILIARY LIVER HOMOTRANSPLANTATION. Surg Gynecol Obstet (1965) 3.15
Homotransplantation of the Canine Liver as an Orthotopic Vascularized Graft: Histologic and Functional Correlations During Residence in the New Host. Am J Pathol (1962) 3.14
Hypotension (shock) in dogs produced by Escherichia coli endotoxin. Circ Res (1956) 2.90
MECHANISM OF REJECTION OF HOMOTRANSPLANTED KIDNEYS. Nature (1963) 2.75
Tolerance and homologous disease in irradiated mice protected with homologous bone marrow. Ann N Y Acad Sci (1958) 2.69
The action in the perfused liver of acetylcholine, sympathomimetic substances and local anaesthetics. J Physiol (1940) 2.52
IMMUNOSUPPRESSION AND VASCULAR INSUFFICIENCY IN LIVER TRANSPLANTATION. Ann N Y Acad Sci (1964) 2.29
THE ROLE OF ADRENOCORTICAL STEROIDS IN REVERSING ESTABLISHED HOMOGRAFT REJECTION. Surgery (1964) 2.26
EXPERIMENTAL AND CLINICAL HOMOTRANSPLANTATION OF THE LIVER. Ann N Y Acad Sci (1964) 2.15
SPLENIC HOMOTRANSPLANTATION. Ann N Y Acad Sci (1964) 2.01
Studies of hepatic function in dogs with Eck fistula or portacaval transposition. AMA Arch Surg (1957) 1.90
[ATTEMPTED HEPATIC HOMOGRAFT]. Mem Acad Chir (Paris) (1964) 1.84
ANALYSIS OF MECHANISM OF IMMUNOSUPPRESSIVE DRUGS IN RENAL HOMOTRANSPLANTATION. Ann Surg (1964) 1.81
Blood supply of the common bile duct. Surg Gynecol Obstet (1963) 1.75
Hepatotoxic agents; mechanism of action and dietary interrelationship. Pharmacol Rev (1952) 1.73
THE ROLE OF LYMPHOCYTES IN THE REJECTION OF CANINE RENAL HOMOTRANSPLANTS. Lab Invest (1964) 1.71
Studies on the reaction of injected homologous lymphoid tissue cells against the host. Ann N Y Acad Sci (1958) 1.67
THE EFFECT OF PORTACAVAL TRANSPOSITION ON CARBOHYDRATE METABOLISM: EXPERIMENTAL AND CLINICAL OBSERVATIONS. Surgery (1965) 1.66
The lipotropic factors in experimental cirrhosis. Br Med J (1948) 1.66
Acute hepatic ischemia in dogs. Surg Gynecol Obstet (1956) 1.64
Marked lipemia resulting from the administration of cortisone. Bull Johns Hopkins Hosp (1951) 1.61
CLINICAL EXPERIENCE WITH ORGAN TRANSPLANTATION. South Med J (1965) 1.58
Biochemical and physiological studies on the viable extracorporeal liver. Surg Forum (1960) 1.57
STUDIES OF REJECTION OF THE HOMOTRANSPLANTED CANINE LIVER. Surg Forum (1963) 1.48
Effects of long-term 6-mercaptopurine treatment upon kidney homotransplants in dogs. Surgery (1963) 1.45
6-Mercaptopurine: effects in mouse sarcoma 180 and in normal animals. Cancer Res (1953) 1.41
Histopathologic alterations associated with the transplanted homologous dog liver. Exp Mol Pathol (1962) 1.29
FUNCTION OF THE EX-VIVO PIG LIVER PERFUSED WITH HUMAN BLOOD. Surg Forum (1964) 1.28
HOMOTRANSPLANTATION OF THE CANINE LIVER. A NEW TECHNIC. Ann Surg (1964) 1.24
Canine liver homotransplants. The effect of host and graft irradiation. Arch Surg (1962) 1.23
Hepatic function after canine liver transplantation. Arch Surg (1962) 1.21
Isolated liver perfusion for reducing blood ammonia. Arch Surg (1961) 1.21
IMMUNOLOGIC OBSERVATIONS ON HOMOGRAFTS. I. THE CANINE LIVER. Transplantation (1965) 1.21
Adult tolerance induced by 6-methyl mercaptopurine to a canine renal homograft. Nature (1963) 1.17
HEPATOTOXICITY OF MERCAPTOPURINE. JAMA (1964) 1.16
HOMOTRANSPLANTATION OF THE CANINE LIVER: SURVIVAL AND HISTOLOGY WITH AND WITHOUT AZATHIOPRINE. Arch Surg (1965) 1.15
Studies on hepatic blood flow and the rate of bromsulphalein clearance in dogs with portacaval transposition. Surgery (1962) 1.12
"Immunoblasts" and "immunocytes"--an attempt at a functional nomenclature. Blood (1963) 1.11
Hepatitis in association with prolonged 6-mercaptopurine therapy. Blood (1959) 1.10
Effect of choline supplements on fatty metamorphosis and liver cell damage in choline and protein deficiency. J Nutr (1953) 1.10
The relation between hepatic flow and function in normal dogs and dogs with cirrhosis after portacaval shunt or transposition. Surg Forum (1960) 1.06
Treatment of experimental dietary cirrhosis of the liver in rats. J Exp Med (1949) 1.02
Liver blood flow, hepatic glucose production, and splanchnic oxygen consumption in normal dogs and following Eck fistula; liver blood flow before and after splenectomy. Surg Gynecol Obstet (1952) 1.01
EFFECT OF SPLEEN HOMOTRANSPLANTS IN ANIMALS SUBJECTED TO SUBLETHAL DOSES OF TOTAL BODY IRRADIATION. Surg Forum (1963) 1.00
EXPERIMENTAL STUDIES ON HOMOLOGOUS HETEROTOPIC LIVER TRANSPLANTATION. Surg Gynecol Obstet (1964) 0.96
Effect of impaired hepatic circulation on plasma free amino acids of dogs. Am J Physiol (1949) 0.96
Lipotropic effects of vitamin B12 and other factors. Ann N Y Acad Sci (1954) 0.96
A new Anaërobic spore-bearing Bacterium commonly Present in the Livers of healthy Dogs, and believed to be responsible for many Changes attributed to aseptic Autolysis of Liver Tissue. J Med Res (1909) 0.95
ANALYSIS OF MECHANISM OF DRUG INDUCED TOLERANCE IN CANINE RENAL HOMOTRANSPLANTS. Surg Forum (1963) 0.93
THE USE OF CADAVER TISSUES IN TRANSPLANTATION. N Engl J Med (1964) 0.93
The effect on liver structure of treatment with adrenocorticotropin under varied dietary conditions. Am J Anat (1948) 0.90
Observations on the hepatic venous circulation with special reference to the sphincteric mechanism. Am J Physiol (1949) 0.89
Hepatomegaly with fatty infiltration secondary to cortisone therapy: case report. Gastroenterology (1952) 0.87
The influence of cortisone and ACTH on experimental zonal necrosis of the liver. J Pathol Bacteriol (1955) 0.84
FUNCTION OF CADAVER LIVER. Surgery (1965) 0.83
Experimental production of hepatocellular damage with cortisone. Surg Forum (1960) 0.83
[Fatty liver and fat embolism]. Dtsch Med Wochenschr (1962) 0.83
Biological incompatibility in kidney transplantation in dogs. II. Serological investigations. Acta Pathol Microbiol Scand (1953) 0.81
A study of the genesis of shock associated with experimentally induced hepatic necrosis in dogs. Surgery (1956) 0.80
COLD PRESERVATION OF LIVER FOR HOMOTRANSPLANTATION. Surg Forum (1964) 0.79
Portal pressure gradients under experimental conditions, including hemorrhagic shock. Am J Physiol (1946) 0.79
Comparison of some metabolic and morphologic effects of cortisone and hydrocortisone given by continuous injection to rats. Am J Physiol (1952) 0.78
METHIONINE PROTECTS AGAINST MAPHARSEN LIVER INJURY IN PROTEIN-DEPLETED DOGS. J Exp Med (1944) 0.77
Influence of choline, cystine and methionine on toxic effects of pyridine and certain related compounds. Proc Soc Exp Biol Med (1948) 0.76
Evolution of liver transplantation. Hepatology (1982) 19.54
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med (1967) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Changes in blood coagulation. Arch Surg (1966) 3.22
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18
Renal transplantation in baboons under FK 506. Surgery (1989) 3.17
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03
Experience with 150 liver resections. Ann Surg (1983) 3.01
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Death after transplantation; an analysis of sixty cases. Am J Med (1967) 2.99
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98
Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95